Drug intelligence / Profile preview

rubus coreanus extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Rubus coreanus extract (RCE) is a natural product being investigated for its anticancer properties, particularly in combination with oxaliplatin for colorectal cancer. It functions by exerting a programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) blockade, thereby enhancing T cell-mediated antitumor immunity. Studies have shown that RCE combined with oxaliplatin activates hPD-1 tumor-infiltrating CD8+ T cells, leading to increased levels of interleukin-2 (IL-2) and granzyme B (GrB), and effectively killing hPD-L1 MC38 colorectal cancer cells. This combination therapy has also been observed to reduce tumor growth and increase the infiltration and GrB production of CD8+ T cells in the tumor microenvironment in humanized PD-1/PD-L1-expressing mouse models, suggesting its potential to improve immune checkpoint blockade therapy when combined with standard chemotherapy regimens in colorectal cancer.

Other names
Unripe Rubus coreanus Miquel extractRubus coreanus Miquel
02

Targets

PDCD1 (Programmed cell death protein 1 receptor)CD274 (Programmed cell death protein 1 ligand 1)

Beyond the preview

Go deeper on rubus coreanus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rubus coreanus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call